Eye Cream Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Dr.Melaxin is the best-performing eye cream brand in July 2026, moving 70,000 units across 1 ASIN for 21.2% of Top 10 volume. BIODANCE follows with 60,000 units (18.2%), ahead of Good Molecules on 50,000 units (15.2%).

Volume is spread across 8 brands, with the top three holding 54.5% between them. No single label controls the shelf, which usually leaves room for a well-differentiated listing to take share without outspending an incumbent. Average selling prices among the leaders run from $5.89 to $23.00, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B0CC6PG567 booked 10K units at $24.74, with ▲ 66.7% MoM change. On the growth side, B07BYG7D2V leads positive momentum with ▲ 250.0% MoM growth on 7K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.